February 23, 2009 - Neuisys Imaging System Solutions announced that the FDA has granted 510(k) clearance of the NeuViz 16, a multislice computed tomography (CT) system, which was developed by Philips Neusoft Medical Systems, a joint venture between Royal Philips Electronics of the Netherlands and Neusoft Corporation of China. The NeuViz 16 is said to provide sub-millimeter resolution, volume imaging and low-dose protocols, all in an economical footprint. The system is suited for diagnostic imaging centers and community hospitals that plan to upgrade from older single or multi-slice CT systems to 16-slice CT as well as a wide array of specialist physician groups considering in-office CT including urologists, gastroenterologists, pulmonologists, surgeons and oncologists. "With the NeuViz 16, physician groups can now routinely provide their patients with convenient, highly advanced in-office CT imaging, shortening the stressful time between testing and diagnosis report to the patient," said Joseph Jenkins, M.D., Neuisys chief medical officer. "The NeuViz 16 provides many advanced clinical applications including CT angiography of peripheral and neuro vasculature, virtual colonoscopy, lung nodule protocols, pulmonary embolism protocols, CT urography and tissue perfusion studies." For more information: www.neuisys.com
Technology | February 23, 2009
FDA Clears NeuViz 16 Multislice CT System
News | Computed Tomography (CT) | September 17, 2018
September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare
News | Computed Tomography (CT) | September 05, 2018
The Center for Diagnostic Imaging (CDI) in Miami recently released a list of important preparations patients should...
Videos | Computed Tomography (CT) | July 25, 2018
A discussion with Patricia Dickson, LRT(CT), director of imaging and outpatient services, Capital Cardiology Associat
Videos | Computed Tomography (CT) | July 23, 2018
Ed Nicol, M.D., FSCCT, MBA, head of cardiac CT, Royal Brompton Hospital, London, and chair of the Society of Cardiova
Videos | Computed Tomography (CT) | July 17, 2018
An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Tri
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
News | Computed Tomography (CT) | July 09, 2018
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center...
Feature | Computed Tomography (CT) | May 29, 2018
May 29, 2018 — Results from the innovative SYNTAX III Revolution Trial  underline the effectiveness of evolving no
News | Computed Tomography (CT) | May 01, 2018
James K. Min, M.D., FSCCT, has been selected for a five-year term as the new editor-in-chief of the Journal of...
Technology | Computed Tomography (CT) | April 18, 2018
April 18, 2018 — The U.S.